期刊文献+

老年直肠癌患者低位前切除术中植入5-氟尿嘧啶缓释剂的临床研究 被引量:5

Clinical research of implant of sustained release 5-fluorouracil during low anterior resection of rectal cancer in elderly patients
下载PDF
导出
摘要 目的探讨老年直肠癌患者行低位前切除术中植入5-氟尿嘧啶缓释剂的安全性及治疗效果。方法分析2013年1月~2015年6月在北京友谊医院普外科行Dixon术老年直肠癌患者78例临床资料,随机分为两组。实验组43例直肠癌患者行标准根治性手术,术中腹腔内植入缓释性5-氟尿嘧啶:对照组35例,予以单纯根治手术而不植入缓释性5-氟尿嘧啶。术前及术后检测两组患者的白细胞计数、肝肾功能、营养状态指标及免疫功能指标,观察患者住院天数、并发症发生情况。结果两组患者术前白细胞计数(WBC)、肝肾功能、营养与免疫球蛋白指标比较差异无统计学意义(P〉0.05)。实验组术后7d与术前1d比较WBC升高,差异有统计学意义(P〈0.05),对照组WBC术后与术前比较,差异无统计学意义(P〉0.05);两组患者术后丙氨酸转氨酶(ALT)、天冬氨酸转氨酶(AST)、血清肌酐(Cr)、血尿素氮(BUN)较术前升高,其中实验组ALT、Cr比较差异有统计学意义(P〈0.05)。术后实验组WBC、A坍、Cr较对照组指标明显升高,差异有统计学意义(P〈0.05)。实验组术后7d与术前1d比较总蛋白(TP)、前白蛋白(PA)、免疫球蛋白A(IgA)明显下降,差异有统计学意义(P〈0.05),对照组术后与术前指标比较,差异无统计学意义(P〉0.05)。实验组术后TP、PA、IgA低于对照组,差异有统计学意义(P〈0.05),其他营养状态指标和免疫球蛋白指标比较差异均无统计学意义(P〉0.05)。术后实验组发热、腹泻发生率较高且腹腔引流量明显多于对照组,差异有统计学意义(P〈0.05)。结论老年直肠癌患者低位前切除术中植入5-氟尿嘧啶缓释剂对患者免疫功能有一定的抑制作用,但未延长术后住院时间,具有较高的安全性,值得临床推广。 Objective To investigate the safety and clinical efficacy of implant of sustained release 5-fluorouracil un- dergoing low anterior resection of rectal cancer in elderly patients. Methods 78 cases of elderly patients with rectal cancer from January 2013 to June 2015 in Beijing Friendship Hospital were randomly divided into experimental group and control group. Sustained release 5-fluorouracil were implant intra-abdominally in 43 patients undergoing low rectal cancer surgery in the experimental group, while 35 cases undergoing radical operation only served as controls. The WBC counting, liver and kidney function, nutrition and immune parameters were detected pre-operatively and post-op- eratively, the days of hospitalization and the occurrence of complications were observed. Results There was no statisti- cally significant difference of WBC counting, liver and kidney function, nutrition and immune parameters of two groups (P 〉 0.05). Postoperative WBC counting of the experimental group was higher than preoperative, and the difference was statistically significant (P 〈 0.05). There was no sig- nificant difference of the pre-operatively and post- operatively WBC counting in the control group (P 〉 0.05). The postoperative ALT, AST, Cr and BUN of two groups were higher than preoperative, and the differences of ALT and Cr in the experimental group were statistically significant (P 〈 0.05). Postoperative WBC counting, ALT, Cr of the experimental group were signifi- cantly higher than those of the control group (P 〈 0.05). Postoperative TP, PA and |gA levels of the experimental group was higher than preoperative, and the difference was statistically significant (P 〈 0.05). There was no significant differ- ence of the pre-operatively and post-operatively nutrition and immune parameters in the control group (P 〉 0.05). Postoperative TP, PA and IgA levels of the experimental group were significantly lower than those of the control group (P 〈 0.05), and there was no significant difference in other immune parameters (P 〉 0.05). The incidence rate of fever, diarrhea and abdominal drainage volume in the experimental group were significantly higher than those in the control group (P 〈 0.05). Conclusion Implant of sustained release 5-fluorouracil during low anterior resection of rectal cancer may inhibit the immune function in elderly patients, but no increase the days of hospitalization, it has high security and is worthy of clinical application.
出处 《中国医药导报》 CAS 2016年第21期164-167,172,共5页 China Medical Herald
基金 首都医科大学基础临床科研合作课题(16JL37)
关键词 老年 直肠癌 低位前切除术 5-氟尿嘧啶缓释剂 Elderly patients Rectal cancer Lowanterior resection Sustained release 5-fiuorouracil
  • 相关文献

参考文献20

  • 1Chen W,Zheng R, Baade PD, et al. Cancer statistics in China,2015 [J]. CA Cancer J Clin,2016,66(2) : 115-132.
  • 2De PA, Innocente R, Buonadonna A, et al. Neoadjuvant therapy of rectal cancer new treatment perspectives [J]. Tumori, 2004,90(4) : 373-378.
  • 3中华人民共和国卫生和计划生育委员会医政医管局,中华医学会肿瘤学会分会.中国结直肠癌诊疗规范(2015版)[J].中华普通外科学文献(电子版),2015,9(6):506-523. 被引量:353
  • 4林志东,毛盛名,卜巨源,邹劲林.大肠癌术中植入氟尿嘧啶缓释剂安全性及其临床疗效的研究[J].中华普通外科学文献(电子版),2013,7(5):32-35. 被引量:7
  • 5Sieqel R,Ma J,Miller K,Jemal A. Cancer Statistics,2016 [J]. CA Cancer J Clin,2016,66:7-30.
  • 6Sethna KS, Sugarbaker PH. New prospects for the control of peritoneal surface dissemination of gastric cancer using perioperativeintraperitoneal chemotherapy[J].CancerTherapy, 2004,2 (A) : 79-84.
  • 7Kim MS,Choi C,Yoo S,et al. Stereotactic body radiation therapy in patients with pelvic recurrence from rectal carcinoma [J]. Jpn J Clin Oncol, 2008,38(10):695-700.
  • 8Glehen O, Gilly FN, Sugarbaker PH. New perspectives in the management of colorectal cancer:what about peritoneal carcinomatosis [J]. Scand J Surg,2003,92(2) : 178- 179.
  • 9Moertel CG. Chemotherapy for colorectal cancer [J]. N Engl J Med, 1994,330(16) : 1136-1142.
  • 10杜卫东,袁祖荣,沈达明,钱敏,唐健雄,庄舜玖,程爱群,于晓峰,竺越.术后腹腔化疗对老年结直肠癌患者生存质量的影响[J].老年医学与保健,2004,10(1):29-31. 被引量:4

二级参考文献133

共引文献498

同被引文献31

引证文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部